Meta AnalysisID 6719
补脾益肠丸联合常规西药治疗肠易激综合征的Meta分析
CRD42023417701
How is the efficacy and safety of the combination of Bupi Yichang Pill and conventional Western medicine therapy for the treatment of Irritable Bowel Syndrome？
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6719
- Evidence Id
- 15277
- Core Evidence Id
- 15277
- Source Meta Analysis Id
- 6702
- Herb2 Meta Analysis Id
- HBMA006702
- Crd Id
- CRD42023417701
- Title
- A meta-analysis of the combination of Bupi Yichang Pill and conventional western therapy for the treatment of Irritable Bowel Syndrome
- Review Question
- How is the efficacy and safety of the combination of Bupi Yichang Pill and conventional Western medicine therapy for the treatment of Irritable Bowel Syndrome？
- Study Type Included
- We will include randomized controlled trials to assess the beneficial effects and harms of the treatments
- Condition Being Studied
- Irritable bowel syndrome； intestinal dysfunction；gastrointestinal motility abnormalities；visceral sensory abnormalities；brain gut regulation abnormalities
- Participant
- Inclusion: People who meet the diagnostic criteria for Irritable bowel syndrome（Standard for diagnosis and treatment of Irritable bowel syndrome） Exclusion:Other gastrointestinal diseases
- Animal
- Human Disease Modelled
- Intervention
- Use the Bupi Yichang Pill add conventional western medicine
- Comparator Control
- conventional western medicine
- Main Outcome
- Total effective rate of treatment；Time for disappearance of abdominal pain, diarrhea, and bloating；Abdominal pain, diarrhea, and bloating scores
- Outcome Measure
- Additional Outcome
- IL-8, IL-6, and TNF-α in plasma；SS，VIP and MTL in plasma
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Acupuncture Therapy; Humans; Irritable Bowel Syndrome; Medicine
- Contact
- Can Cao [email protected]
- Organisational Affiliation
- Beijing University of Chinese Medicine
- Funding Source
- National Key Basic Research Development Plan (973 Plan) (2011 CB505300; 2011 CB505306)
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-04-16
- Registration Date
- 2023-04-27
- Anticipated Start Date
- 2024-01-31
- Anticipated Completion Date
- 2024-09-30
- Title Cn
- 补脾益肠丸联合常规西药治疗肠易激综合征的Meta分析
- Title En
- A meta-analysis of the combination of Bupi Yichang Pill and conventional western therapy for the treatment of Irritable Bowel Syndrome
- Bilingual Status
- complete